Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterNo recent work listed

Libo Yin

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5075004812. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2018: 1 paper · 2019: 3 papers · 2020: 3 papers · 2021: 1 paper · 2022: 1 paper

Papers 9

  1. microRNA-497 prevents pancreatic cancer stem cell gemcitabine resistance, migration, and invasion by directly targeting nuclear factor kappa B 1. Co-author DOI 10.18632/aging.204193↗
  2. Sulforaphane Inhibits the Expression of Long Noncoding RNA H19 and Its Target APOBEC3G and Thereby Pancreatic Cancer Progression. Co-author DOI 10.3390/cancers13040827↗
  3. Inhibition of miR30a-3p by sulforaphane enhances gap junction intercellular communication in pancreatic cancer. First author DOI 10.1016/j.canlet.2019.10.042↗
  4. Novel plant microRNAs from broccoletti sprouts do not show cross-kingdom regulation of pancreatic cancer. Co-author DOI 10.18632/oncotarget.27527↗
  5. Novel Broccoli Sulforaphane-Based Analogues Inhibit the Progression of Pancreatic Cancer without Side Effects. Co-author DOI 10.3390/biom10050769↗
  6. MicroRNA-365a-3p inhibits c-Rel-mediated NF-κB signaling and the progression of pancreatic cancer. Co-author DOI 10.1016/j.canlet.2019.03.025↗
  7. Sulforaphane Induces miR135b-5p and Its Target Gene, RASAL2, thereby Inhibiting the Progression of Pancreatic Cancer. Co-author DOI 10.1016/j.omto.2019.03.011↗
  8. Interleukin 21 Receptor/Ligand Interaction Is Linked to Disease Progression in Pancreatic Cancer. Co-author DOI 10.3390/cells8091104↗
  9. Simvastatin inhibits sonic hedgehog signaling and stemness features of pancreatic cancer. Co-author DOI 10.1016/j.canlet.2018.04.001↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ingrid Herr · 8 shared papers, 2018–2021 · strength 0.80
  2. Christina Georgikou · 5 shared papers, 2019–2020 · strength 0.51
  3. Xi Xiao · 4 shared papers, 2019–2020 · strength 0.40
  4. Yiqiao Luo · 3 shared papers, 2019–2021 · strength 0.31
  5. Svetlana Karakhanova · 3 shared papers, 2019–2020 · strength 0.29
  6. Li Liu · 3 shared papers, 2019–2020 · strength 0.29
  7. Yefeng Yin · 3 shared papers, 2018–2020 · strength 0.26
  8. Thilo Hackert · 2 shared papers, 2018–2019 · strength 0.16
  9. Wenlong Zeng · 1 shared paper, 2022 · strength 0.15
  10. Qiangfeng Yu · 1 shared paper, 2022 · strength 0.15
  11. Jianyin Zhou · 1 shared paper, 2022 · strength 0.15
  12. Xuefeng An · 1 shared paper, 2021 · strength 0.13
  13. Bin Yan · 1 shared paper, 2021 · strength 0.13
  14. Li Liu · 1 shared paper, 2021 · strength 0.13
  15. Alica Linnebacher · 1 shared paper, 2019 · strength 0.09
  16. Li Liu · 1 shared paper, 2019 · strength 0.09
  17. Matthias M. Gaida · 1 shared paper, 2019 · strength 0.09
  18. Philipp Mayer · 1 shared paper, 2019 · strength 0.09
  19. Nathalie Bauer · 1 shared paper, 2018 · strength 0.07
  20. Clifford C. Nwaeburu · 1 shared paper, 2018 · strength 0.07
  21. Oliver Strobel · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.